Blood Test for Colon Cancer Staging
Part of Cancer, Digestive system clinical trials.
This study looks at a new blood test that may help doctors better understand how far colon cancer has spread. By testing a sample of your blood (taken before surgery), researchers hope to find patterns that predict the stage of cancer and help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with colon cancer that has spread to 1 to 4 nearby lymph nodes. (This is called stage III colon cancer.)
- You have had surgery to remove the colon cancer with the goal of curing it. (You may also have had chemotherapy or radiation before or after surgery.)
- A blood sample was taken before your surgery (or before any treatment started) and is available for testing.
- Your medical records include information about your recovery and whether the cancer came back after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether measuring certain blood markers can help track how well treatment is working in people with stage III colon cancer. It may help doctors understand if the cancer is responding to therapy before surgery.
This trial uses a simple blood test to look for tiny bits of tumor DNA after colon cancer surgery. If found, it may help doctors catch any remaining cancer early and guide further treatment.
This study tests a new blood test that might help detect colorectal cancer. If you're already planning a colonoscopy or colorectal surgery, your participation could help improve early detection.
This study uses a simple blood test to detect cancer DNA after surgery for early-stage colon cancer. The goal is to help doctors decide whether chemotherapy is truly needed based on the blood test results, rather than giving it to everyone.
This study looks at special tiny cell-signal particles (called exosomes) and related pathways to understand colorectal cancer. Your results from samples may help researchers learn how these signals relate to the disease after surgery.
This trial is studying a blood test that looks for tiny bits of cancer DNA after surgery for stage III colorectal cancer. The goal is to find out how well this test can predict whether cancer might come back, so you and your doctor can make better treatment decisions.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.